tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PVLA Stock Latest News

Palvella Therapeutics (PVLA): Mechanistic Validation, Unmet Need, and Pivotal Trial Catalysts Underpin Buy Rating
RatingsPalvella Therapeutics (PVLA): Mechanistic Validation, Unmet Need, and Pivotal Trial Catalysts Underpin Buy Rating
19d ago
PVLA
Palvella Therapeutics management to meet virtually with Craig-Hallum
PremiumThe Fly
Palvella Therapeutics management to meet virtually with Craig-Hallum
20d ago
PVLA
Palvella Therapeutics price target raised to $190 from $133 at TD Cowen
PremiumThe Fly
Palvella Therapeutics price target raised to $190 from $133 at TD Cowen
20d ago
PVLA
Palvella Therapeutics announces publication of review on Qtorin
PremiumThe Fly
Palvella Therapeutics announces publication of review on Qtorin
20d ago
PVLA
3 Best Stocks to Buy Today, 2/2/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 2/2/2026, According to Top Analysts
20d ago
PAR
ADSK
Palvella Highlights QTORIN Rapamycin Progress in New Presentation
PremiumCompany AnnouncementsPalvella Highlights QTORIN Rapamycin Progress in New Presentation
23d ago
8K
PVLA
3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
24d ago
CRVS
NRIX
Physician Survey Underscores Undervalued Commercial Upside for QTORIN Topical Rapamycin, Supporting Buy on Palvella Therapeutics
Premium
Ratings
Physician Survey Underscores Undervalued Commercial Upside for QTORIN Topical Rapamycin, Supporting Buy on Palvella Therapeutics
1M ago
PVLA
Palvella Therapeutics management to meet with Clear Street
PremiumThe Fly
Palvella Therapeutics management to meet with Clear Street
1M ago
PVLA
Palvella Highlights QTORIN Pipeline and 2026 Growth Outlook
PremiumCompany Announcements
Palvella Highlights QTORIN Pipeline and 2026 Growth Outlook
1M ago
8K
PVLA
Palvella Therapeutics management to meet with H, C, Wainwright
PremiumThe Fly
Palvella Therapeutics management to meet with H, C, Wainwright
1M ago
PVLA
BUY Rating on Palvella Therapeutics: De-Risked SELVA Phase 3 Design Positions QTORIN Rapamycin for First-in-Class MLM Approval and Compelling Risk–Reward
PremiumRatings
BUY Rating on Palvella Therapeutics: De-Risked SELVA Phase 3 Design Positions QTORIN Rapamycin for First-in-Class MLM Approval and Compelling Risk–Reward
1M ago
PVLA
Palvella Therapeutics issues update, 2026 outlook
PremiumThe FlyPalvella Therapeutics issues update, 2026 outlook
1M ago
PVLA
Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
Premium
The Fly
Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
2M ago
W
HSY
Palvella Therapeutics appoints Vimal Patel as SVP, medical affairs
Premium
The Fly
Palvella Therapeutics appoints Vimal Patel as SVP, medical affairs
2M ago
INCY
PVLA
Palvella Therapeutics initiated with an Outperform at Mizuho
PremiumThe Fly
Palvella Therapeutics initiated with an Outperform at Mizuho
2M ago
PVLA
Palvella Therapeutics price target raised to $133 from $97 at TD Cowen
PremiumThe Fly
Palvella Therapeutics price target raised to $133 from $97 at TD Cowen
2M ago
PVLA
Palvella Therapeutics granted FDA Fast Track Designation to QTORIN
PremiumThe Fly
Palvella Therapeutics granted FDA Fast Track Designation to QTORIN
2M ago
PVLA
Palvella Therapeutics price target raised to $204 from $148 at Canaccord
PremiumThe Fly
Palvella Therapeutics price target raised to $204 from $148 at Canaccord
2M ago
PVLA
Buy Rating Affirmed for Palvella Therapeutics Following Promising Phase 2 TOIVA Trial Results
PremiumRatingsBuy Rating Affirmed for Palvella Therapeutics Following Promising Phase 2 TOIVA Trial Results
2M ago
PVLA
Palvella Therapeutics price target raised to $174 from $110 at Chardan
Premium
The Fly
Palvella Therapeutics price target raised to $174 from $110 at Chardan
2M ago
PVLA
Palvella Therapeutics price target raised to $190 from $105 at Truist
Premium
The Fly
Palvella Therapeutics price target raised to $190 from $105 at Truist
2M ago
PVLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >